cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]
cholestyramine resin
RxCUI: 848949
What the CMS Formulary Data Shows for cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]
Per the CMS 2026 Part D formulary file, cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] (RxNorm concept RXCUI 848949, generic name cholestyramine resin) appears on 1 distinct formulary file spanning 6 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 2, with a cross-plan average of Tier 2.
Real-world access to cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 186,287 Part D beneficiaries filled cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] in 2023, with total plan-and-beneficiary spending of $47,731,557 and an average per-beneficiary annual cost of $256.23. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 6
- Coverage rate
- 0.1%
- Tier range
- Tier 2, Generic
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 186,287
- Total spending
- $47,731,557
- Avg per beneficiary
- $256.23
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]
6 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T2 | No | $47.00 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T2 | No | $59.70 | PA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T2 | No | $63.50 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T2 | No | $79.70 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T2 | No | $102.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T2 | No | $112.70 | PA |
Frequently Asked Questions
Is cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] covered by Medicare Part D?
Yes, cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] is covered by 6 Medicare Part D plans (0.1% of all Part D formularies).
What tier is cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] on Medicare Part D plans?
cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] averages Tier 2 across Part D plans, ranging from Tier 2 to Tier 2.
Does cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] require prior authorization?
0% of Part D formularies require prior authorization for cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on cholestyramine resin 4000 MG Powder for Oral Suspension [Questran]?
In 2023, total Medicare Part D spending on cholestyramine resin 4000 MG Powder for Oral Suspension [Questran] was $47,731,557, covering 186,287 beneficiaries. The average spend per beneficiary was $256.23.
Read our methodology - how this data is sourced, computed, and verified.